|
1
|
The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD.
|
Am J Respir Crit Care Med
|
2010
|
1.56
|
|
2
|
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
|
JAMA
|
2012
|
1.47
|
|
3
|
Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis.
|
J Immunol
|
2004
|
1.24
|
|
4
|
Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity.
|
J Infect Dis
|
2003
|
1.16
|
|
5
|
Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012.
|
Emerg Infect Dis
|
2015
|
1.08
|
|
6
|
Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo.
|
Proc Natl Acad Sci U S A
|
2010
|
1.07
|
|
7
|
Tissue microarrays from HOPE-fixed specimens allow for enhanced high throughput molecular analyses in paraffin-embedded material.
|
Pathol Res Pract
|
2005
|
1.04
|
|
8
|
Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections.
|
J Immunol
|
2008
|
1.01
|
|
9
|
The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae.
|
Respir Res
|
2010
|
1.00
|
|
10
|
Targeting of a chlamydial protease impedes intracellular bacterial growth.
|
PLoS Pathog
|
2011
|
0.98
|
|
11
|
Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection.
|
Am J Respir Cell Mol Biol
|
2008
|
0.98
|
|
12
|
Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.
|
Am J Respir Crit Care Med
|
2007
|
0.97
|
|
13
|
Nontypeable Haemophilus Influenzae Infection Upregulates the NLRP3 Inflammasome and Leads to Caspase-1-Dependent Secretion of Interleukin-1β - A Possible Pathway of Exacerbations in COPD.
|
PLoS One
|
2013
|
0.97
|
|
14
|
The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease.
|
Am J Pathol
|
2010
|
0.96
|
|
15
|
Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.
|
Circulation
|
2003
|
0.96
|
|
16
|
Genetic diversity of the obligate intracellular bacterium Chlamydophila pneumoniae by genome-wide analysis of single nucleotide polymorphisms: evidence for highly clonal population structure.
|
BMC Genomics
|
2007
|
0.94
|
|
17
|
The interleukin-6 -174 promoter polymorphism is associated with extrapulmonary bacterial dissemination in Streptococcus pneumoniae infection.
|
Cytokine
|
2005
|
0.92
|
|
18
|
Be aware of the possibility of false-positive results in single-locus PCR assays for methicillin-resistant Staphylococcus aureus.
|
J Clin Microbiol
|
2006
|
0.91
|
|
19
|
Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.
|
Antimicrob Agents Chemother
|
2011
|
0.91
|
|
20
|
Chlamydophila pneumoniae. Mechanisms of target cell infection and activation.
|
Thromb Haemost
|
2005
|
0.91
|
|
21
|
First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae.
|
Antimicrob Agents Chemother
|
2004
|
0.91
|
|
22
|
Experimental induction and three-dimensional two-photon imaging of conjunctiva-associated lymphoid tissue.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.89
|
|
23
|
Mechanisms of cilia-driven transport in the airways in the absence of mucus.
|
Am J Respir Cell Mol Biol
|
2014
|
0.88
|
|
24
|
Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions.
|
PLoS One
|
2013
|
0.88
|
|
25
|
Fluorescence lifetime imaging unravels C. trachomatis metabolism and its crosstalk with the host cell.
|
PLoS Pathog
|
2011
|
0.86
|
|
26
|
Molecular cartography in acute Chlamydia pneumoniae infections--a non-targeted metabolomics approach.
|
Anal Bioanal Chem
|
2013
|
0.86
|
|
27
|
When oxygen runs short: the microenvironment drives host-pathogen interactions.
|
Microbes Infect
|
2011
|
0.84
|
|
28
|
Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?
|
Med Microbiol Immunol
|
2010
|
0.84
|
|
29
|
Asymptomatic carotid atherosclerosis is associated with circulating chlamydia pneumoniae DNA in younger normotensive subjects in a general population survey.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.83
|
|
30
|
Insulin-like growth factor-I regulates the neonatal immune response in infection and maturation by suppression of IFN-γ.
|
Cytokine
|
2012
|
0.83
|
|
31
|
Growth cycle-dependent pharmacodynamics of antichlamydial drugs.
|
Antimicrob Agents Chemother
|
2005
|
0.82
|
|
32
|
Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.
|
Immunobiology
|
2010
|
0.81
|
|
33
|
159C>T CD14 genotype--functional effects on innate immune responses in term neonates.
|
Hum Immunol
|
2008
|
0.80
|
|
34
|
Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.
|
Biochem Biophys Res Commun
|
2004
|
0.79
|
|
35
|
A human fallopian tube model for investigation of C. trachomatis infections.
|
J Vis Exp
|
2012
|
0.79
|
|
36
|
NOD2 Loss-of-Function Mutations and Risks of Necrotizing Enterocolitis or Focal Intestinal Perforation in Very Low-birth-weight Infants.
|
Inflamm Bowel Dis
|
2016
|
0.78
|
|
37
|
Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia.
|
Antimicrob Agents Chemother
|
2013
|
0.78
|
|
38
|
Imaging of Chlamydia and host cell metabolism.
|
Future Microbiol
|
2014
|
0.77
|
|
39
|
Perfluorocarbons decrease Chlamydophila pneumoniae-mediated inflammatory responses of rat type II pneumocytes in vitro.
|
Pediatr Res
|
2006
|
0.77
|
|
40
|
Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.
|
Thromb Haemost
|
2009
|
0.77
|
|
41
|
Characterizing the intracellular distribution of metabolites in intact Chlamydia-infected cells by Raman and two-photon microscopy.
|
Microbes Infect
|
2013
|
0.77
|
|
42
|
Budesonide Inhibits Intracellular Infection with Non-Typeable Haemophilus influenzae despite Its Anti-Inflammatory Effects in Respiratory Cells and Human Lung Tissue: A Role for p38 MAP Kinase.
|
Respiration
|
2015
|
0.76
|
|
43
|
Host metabolism promotes growth of Chlamydia pneumoniae in a low oxygen environment.
|
Int J Med Microbiol
|
2013
|
0.76
|
|
44
|
Acute kidney injury and thrombocytopenic fever--consider the infrequent causes.
|
Am J Emerg Med
|
2013
|
0.76
|
|
45
|
Critical investigation of the CD14 promoter polymorphism: lack of a role for in vitro cytokine response and membrane CD14 expression.
|
Clin Diagn Lab Immunol
|
2005
|
0.76
|
|
46
|
Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns.
|
Clin Vaccine Immunol
|
2010
|
0.75
|
|
47
|
Egr-1, a major link between infection and atherosclerosis?
|
Circ Res
|
2003
|
0.75
|
|
48
|
Immunomodulatory effects of Sanglifehrin A in the innate and acquired immune response of neonatal whole blood cells.
|
Immunobiology
|
2008
|
0.75
|
|
49
|
Erratum: Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.
|
Nat Med
|
2017
|
0.75
|